Does CEFPODOXIME PROXETIL Cause Bladder transitional cell carcinoma? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Bladder transitional cell carcinoma have been filed in association with CEFPODOXIME PROXETIL (Cefpodoxime Proxetil). This represents 6.5% of all adverse event reports for CEFPODOXIME PROXETIL.
21
Reports of Bladder transitional cell carcinoma with CEFPODOXIME PROXETIL
6.5%
of all CEFPODOXIME PROXETIL reports
0
Deaths
21
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From CEFPODOXIME PROXETIL?
Of the 21 reports, 21 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEFPODOXIME PROXETIL. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does CEFPODOXIME PROXETIL Cause?
Drug hypersensitivity (48)
Diarrhoea (26)
Dizziness (23)
Pyrexia (22)
Vomiting (20)
Nausea (19)
Headache (15)
Rash (15)
Drug ineffective (14)
Abdominal pain (13)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which CEFPODOXIME PROXETIL Alternatives Have Lower Bladder transitional cell carcinoma Risk?
CEFPODOXIME PROXETIL vs CEFPROZIL
CEFPODOXIME PROXETIL vs CEFTAROLINE
CEFPODOXIME PROXETIL vs CEFTAROLINE FOSAMIL
CEFPODOXIME PROXETIL vs CEFTAZIDIME
CEFPODOXIME PROXETIL vs CEFTIBUTEN